Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
Just nowPlacement
Just nowQ3 FY26 Activities Report and Appendix 4C
Just nowFY26 Q1 Quarterly Activities Report and Appendix 4C
Novocure Ltd logo

Novocure Ltd

About

Novocure Ltd (NASDAQ:NVCR) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 1 2026
Novocure to Report First Quarter 2026 Financial Results
Mar 26 2026
Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
Mar 2 2026
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Feb 27 2026
Novocure to Participate in 2026 Leerink Global Healthcare Conference
Feb 26 2026
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

Financials

Revenue
$655.35 M
Market Cap
$1.25 B
EPS
-1.22

Community Chat

Ask AI

6ix6ix